Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody–Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse ModelsHiroyuki Kogai(Eisai (Japan)), Youya Nakazawa(Japanese Foundation For Cancer Research)Molecular Cancer TherapeuticsJanuary 15, 202510.1158/1535-7163.mct-24-0444Cited by 8SaveCiteExport RISWatch citationsRelated PapersPeriostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer|Scientific Reports|2018|74The Novel Metastasis Promoter Merm1/Wbscr22 Enhances Tumor Cell Survival in the Vasculature by Suppressing Zac1/p53-Dependent Apoptosis|Cancer Research|2010|57